BioNxt Solutions Inc

As of June 30, 2026, BioNxt Solutions Inc has 136.09M shares outstanding.

As of June 30, 2026, BioNxt Solutions Inc maintains a current ratio of 0.19, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -106.89, indicating conservative leverage, while an interest coverage ratio of -5.06 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -846.36, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 19.00, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, BioNxt Solutions Inc's stock has declined approximately 55.24% over the past 52 weeks.

Over the twelve months ended June 30, 2026, BioNxt Solutions Inc generated - - in revenue and converted that into -5.64M in net income, yielding earnings per share of -0.05. EBITDA reached -4.85M, while operating income came in at -4.21M.

As of June 30, 2026, BioNxt Solutions Inc holds 741,551.87 in cash and equivalents against 4.12M in total debt, resulting in a net debt position of 3.38M. Total book value stands at -3.86M, with working capital of -3.32M providing operational flexibility.

BioNxt Solutions Inc produced -2.81M in operating cash flow over the twelve months ended June 30, 2026.